{
    "Title": "Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers",
    "URL": "https://doi.org/10.1371/journal.pntd.0006376",
    "Published": "April 6, 2018",
    "Subject_Areas": [
        "Antibody response",
        "Vibrio cholerae",
        "Antibodies",
        "Cholera vaccines",
        "Diarrhea",
        "Immune response",
        "Vaccination and immunization",
        "Vaccine development"
    ],
    "Authors": {
        "Kamrul Islam": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"
        ],
        "Motaher Hossain": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"
        ],
        "Meagan Kelly": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America"
        ],
        "Leslie M. Mayo Smith": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America"
        ],
        "Richelle C. Charles": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Taufiqur Rahman Bhuiyan": [
            "Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"
        ],
        "Pavol Kov\u00e1\u010d": [
            "National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Peng Xu": [
            "National Institute of Diabetes, Digestive and Kidney Diseases (NIDDK), Laboratory of Bioorganic Chemistry (LBC), National Institutes of Health, Bethesda, Maryland, United States of America"
        ],
        "Regina C. LaRocque": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Stephen B. Calderwood": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Jakub K. Simon": [
            "Merck & Co., Inc., Kenilworth, New Jersey, United States of America"
        ],
        "Wilbur H. Chen": [
            "Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America"
        ],
        "Douglas Haney": [
            "PaxVax, Inc., Redwood City, California, United States of America"
        ],
        "Michael Lock": [
            "PaxVax, Inc., Redwood City, California, United States of America"
        ],
        "Caroline E. Lyon": [
            "Vaccine Testing Center, Department of Medicine University of Vermont College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Beth D. Kirkpatrick": [
            "Vaccine Testing Center, Department of Medicine University of Vermont College of Medicine, Burlington, Vermont, United States of America"
        ],
        "Mitchell Cohen": [
            "Cincinnati Children\u2019s Hospital Medical Center, and the Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, United States of America"
        ],
        "Myron M. Levine": [
            "Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, United States of America"
        ],
        "Marc Gurwith": [
            "PaxVax, Inc., Redwood City, California, United States of America"
        ],
        "Jason B. Harris": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, United States of America"
        ],
        "Firdausi Qadri": [
            "Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh"
        ],
        "Edward T. Ryan": [
            "Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America",
            "Harvard Medical School, Boston, Massachusetts, United States of America",
            "Department of Immunology and Infectious Disease, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America"
        ]
    }
}